Deborah Yamamura

, MD, FRCPC

Associate Professor
Pathology and Molecular Medicine

Division: Medical Microbiology

Associate Member: Department of Medicine

Hamilton General Hospital
Microbiology Department, Rm 1-117
Hamilton, Ontario
905-527-4322 ext. 46197
yamamura@hhsc.ca

Assistant: Debbie Reeves

Education and Professional Standing

• FRCPC Infectious Diseases, 1998
• FRCPC Medical Microbiology, 1998
• FRCPC Internal Medicine, 1996
• MD, Queens University, 1992
• BSc, University of Toronto, 1988

---

Interests

Research and Clinical Focus

Main research Areas: Detection of antimicrobial resistance in bacteria, epidemiology of invasive candidiasis, diagnostic medical microbiology, quality management Dr. Yamamura is involved in the evaluation of diagnostic test methods to detect antimicrobial resistance and to detect clinically significant pathogens. Her research interests include the epidemiology of multi-drug resistant bacteria and invasive candidiasis.

Dr. Yamamura is a member of the QMP-LS Mycology Committee involved in external proficiency testing of clinical mycology specimens. She is a member of the Nucleus Committee for Medical Microbiology, Royal College of Physicians and Surgeons of Canada. She has been an assessor for the Ontario Laboratory Accreditation Program and the College of American Pathologists.

Academic Interests

Dr. Yamamura is an Associate Professor in the Department of Pathology and Molecular Medicine and is the Head of Bacteriology and Mycology for the Hamilton Regional Laboratory Medicine Program, and a consultant in infectious diseases for Hamilton Health Sciences.

After earning a degree in palaeontology at the University of Toronto, Dr. Yamamura obtained a degree in Medicine at Queen's University and then completed a fellowship in internal medicine, infectious diseases and medical microbiology at McMaster University. She currently teaches in McMaster's MD Postgraduate Program.

---

Selected Publications

• Narula N, Yamamura DLR, Marshall JK. Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus? Canadian Journal of Gastroenterology 2010;24(2):121-125.
• DLR Yamamura, L. Wilcox, P. Lyn et al. Epidemiology and Prevalence of Invasive Methicillin Resistant Staphylcoccus aureus (MRSA) with Reduced Susceptibility and/or Tolerance to Vancomycin in 2006-2007 in 4 Regions in Ontario, Canada. ICAAC/IDSA Poster D-1156, Washington, 2008.
• Tansey CM, Louise M, Loeb M, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch
  Intern Med. 2007 Jun 25; 167(12):1312-20.
• Yamamura DLR TB Screening. American College of Physicians, PIER module. 2007.
• Schachter ME, Wilcox L, Rau N, Yamamura D, Brown S, Lee CH. Rat-bite fever, Canada [letter]. Emerg Infect Dis Emerg Infect Dis. 2006 Aug; 12(8):1301-2.
• Yamamura DLR. HIV Screening. American College of Physicians, PIER module. 2004
• Pennie RA, Szakacs TA, Smaill FM, Smieja M, Yamamura D, McTaggart B, McCallum A. Short Report: Ceftriaxone for cat and dog bites. Canadian Family Physician 2004; 50:577-579.
• B. Gandhi, L. Cote, SE Richardson, U. Bunn, F. Jamieson, T. Stacey-Works, DLR Yamamura. Comparative Study of API 20C AUX, ID32C and the Vitek 2 ID-YST: Three BioMerieux Yeast Identification Systems, Poster C-270, ASM 2003.
• Marshall JK, Yamamura DLR. A Semiquantitative Stool Antigen Test for Helicobacter Pylori: Shedding New Light? J Clinical Gastroenterol 2002; 35(5):369-70.
• Marshall JK, Cawdron R, Yamamura DLR, Ganguli S, Lad R, O'Brien BJ. Use and misuse of cost-effectiveness terminology in the gastroenterology literature: a systematic review. Am J Gastroenterol 2002;7(1):172-9.
• Yamamura D, Jayaratne P, Wilcox L, Billone J, Rutherford C, Smaill F. Extended-spectrum B-lactamase production in clinical isolates in Hamilton, Ontario: A phenotypic and genotypic analysis. ICAAC,Toronto, 2000
• Yamamura DLR, Mandell LA. Antimicrobial therapy in the patient hospitalized with pneumonia. Sepsis 998,1:189-197.
• Yamamura D, Gucalp R, Carlisle P, et al. Open randomized study of cefepime versus piperacillin-gentamicin for the treatment of febrile neutropenic cancer patients. Antimicrob Agents Chemother 1997; 41:1704-1708.
• Yamamura DLR, Rotstein C, Nicolle LE, et al. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. CMAJ 1999;160:493-499.